Introduction
============

Colorectal cancer (CRC) is the third most commonly diagnosed cancer (1.8 million cases, 10.2 % of the total cancers). CRC is responsible for the second largest number of deaths (881,000 deaths, 9.2 %) [@JR1803-1] . Colonoscopy has been associated with a reduced incidence of CRC. Screening colonoscopy has been associated with reduced CRC mortality [@JR1803-2] . Screening for CRC has resulted in a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions, and incidence reduction and early detection of CRC has in turn resulted in a reduction in CRC mortality [@JR1803-3] . The adenoma detection rate (ADR) is an important quality indicator of colonoscopy and is inversely associated with the risks of interval CRC, advanced-stage interval cancer, and fatal interval cancer [@JR1803-4] [@JR1803-5] . Increased ADR has been reported to be associated with a reduced risk of interval CRC and death [@JR1803-6] . Therefore, it is essential to know the type of adenomas that are missed by endoscopists with low ADR. However, it remains unclear.

We investigated the differences in detected polyps and colonoscopy procedures between patients who underwent colonoscopy by endoscopists with either a high or low ADR.

Patients and methods
====================

Ethics
------

This retrospective study was approved by the Ethical Review Committee of the Hattori Clinic on September 6, 2019 (approval no. S1909-U06). Written informed consent was obtained from the participants. All clinical investigations were conducted according to the ethical guidelines of the Declaration of Helsinki.

Study population
----------------

This propensity-score matching study comprised subjects who agreed to participate in the study and underwent colonoscopy by board-certificated endoscopists at the Toyoshima Endoscopy Clinic, an outpatient clinic specializing in endoscopy, between April and November 2017. Colonoscopy was performed to evaluate symptoms (i. e., bleeding including positive results of fecal occult blood test, abdominal symptoms, and abnormal bowel habits), for screening, or for polyp surveillance. We excluded patients who were not willing to undergo removal of colorectal polyps, patients who had previously been diagnosed with CRC and/or inflammatory bowel disease, and/or had undergone colorectal surgery except appendectomy, and patients who had indications for treatment including colorectal polypectomy and hemostasis. We excluded colonoscopy procedures that did not reach the cecum due to bowel stenosis, procedures with poor bowel preparation precluding complete observation, and procedures that did not remove all the polyps due to the large size and/or number of polyps [@JR1803-7] [@JR1803-8] [@JR1803-9] . We removed polyps numbering 10 or less, those with a diameter of 15 mm or less, and those with a cumulative diameter of 30 mm or less, at a single colonoscopy procedure. Details on baseline characteristics, polyp detection, and colonoscopy procedures were obtained through review of patient medical records.

Diagnosis of polyps
-------------------

To endoscopically diagnose colorectal polyps, we used the updated Paris Endoscopic Classification of superficial neoplastic lesions in the digestive tract [@JR1803-10] . We primarily diagnosed a polyp as a sessile serrated polyp (SSP) according to the following findings: proximal location; flat, elevated, or sessile; irregular shape; indistinctive border; cloud-like surface; mucus cap; normal or pale color; none or dilated vessels, and/or dilated crypts [@JR1803-11] . Polyp size was measured by placing a closed snare or forceps, which has a thickness of 2 mm, against the lesion. Lesions diagnosed as adenomas or SSPs were removed either by hot or cold polypectomy using a snare or forceps or by endoscopic mucosal resection on the examination day.

All resected specimens were examined histologically under hematoxylin and eosin staining. One experienced gastrointestinal pathologist (H.W.) diagnosed the polyps, including adenomas and SSPs, according to the World Health Organization criteria [@BR1803-12] . Traditional serrated adenomas were included in the adenoma category, but SSPs were not. An advanced adenoma was defined as an adenoma with a villous component, with a size larger than 10 mm, or with high-grade dysplasia based on the World Health Organization definition [@BR1803-12] . Low-risk adenomas were defined as one or two tubular adenomas less than 10 mm and high-risk adenomas were defined as at least one advanced adenoma or three or more adenomas [@JR1803-13] . Only lesions that were histologically confirmed as adenomas or SSPs were counted [@JR1803-14] .

Colonoscopy equipment
---------------------

Patients underwent colonoscopy with an Elite CF290 endoscopy system (CV-290 and CLV-290, Olympus, Japan) with a 290 series colonoscope (CF-HQ290Z, CF-HQ290, or PCF-H290Z, Olympus, Japan) or a 260 series colonoscope (PCF-PQ260 or CF-H260) and a carbon dioxide (CO ~2~ ) insufflator (UCR CO ~2~ regulation unit, Olympus, Japan). NBI was available for all the scopes. A flushing pump (OFP-2, Olympus, Japan) was used for the 290 series colonoscope. PCF-H290Z and PCF-PQ260 were used for patients aged 80 years or older, patients aged 70 years or older who had undergone a previous abdominal surgery, and patients likely to experience a difficult insertion due to a colon adhesion found during a previous colonoscopy [@JR1803-9] . We used an image filing system (T-File System; STS Medic, Japan).

Colonoscopy procedure
---------------------

Small shaking, jiggling, and right turn shortening maneuvers have been frequently used for colonoscope insertion [@JR1803-9] . Extra gas and liquid were aspirated and removed as much as possible. For colonic insufflation, CO ~2~ was administered through the UCR for patients without chronic respiratory failure. Colonoscopies were performed under conscious sedation with midazolam (0.5 to 10 mg) and/or pethidine hydrochloride (17.5 to 70 mg) according to the patient's willingness. In the absence of contraindications, we administered 10 to 20 mg of scopolamine butylbromide or 0.5 to 1 mg glucagon (genetic recombinant).

The observation time for withdrawal of the colonoscope was standardized as at least 6 minutes [@JR1803-15] . Pancolonic chromoendoscopy (PCC) was performed at the discretion of each endoscopist. PCC involved pancolonic spraying with 0.05 % indigo carmine using a 20-mL syringe placed directly through the colonoscope accessory channel. We repeated the administration of 5 mL indigo carmine with 10 mL air-spraying 10 to 20 times during the withdrawal procedure, and the pools of excess dye were suctioned before the examination. The colonoscope was sequentially withdrawn as the prescribed position changed [@JR1803-16] [@JR1803-17] : the ascending colon/hepatic flexure was examined in the left lateral decubitus position; the transverse colon was examined in the supine position; the splenic flexure, descending colon, and sigmoid-descending colon junction were examined in the right lateral position; and the sigmoid colon and rectum were examined in the right lateral position.

Patients involved in this study underwent colonic preparation with 2 L of polyethylene glycol solution administered orally 5 hours before the procedure. Polyethylene glycol solution or magnesium citrate was added when the stool was not in the clear liquid form. The quality of bowel preparation was graded as A (all colon segments empty and clean or minor amount of fluid in the gut that was easily removed by suction), B (at least one colon segment with residual amounts of brown liquid or semi-solid stool that could be easily removed or displaced), C (at least one colon segment with only partially removable stool preventing complete visualization of mucosa), or D (at least one colon segment that could not be examined due to the presence of remaining solid stool). The following colon segments were rated: rectum, sigmoid colon, descending colon, transverse colon, and ascending colon/cecum [@JR1803-18] . Patients identified with grade D bowel preparation during the colonoscopy were excluded.

Statistical analysis
--------------------

We calculated average ADR of all enrolled procedures and ADRs for each endoscopist, during the study period. An endoscopist having an ADR higher than the average ADR was defined as a high-ADR endoscopist, and an endoscopist having an ADR lower than the average ADR was defined as a low-ADR endoscopist [@JR1803-19] [@JR1803-20] [@JR1803-21] . We divided the patients into those underwent colonoscopy by a high-ADR endoscopist (the high-ADR group) and those who underwent colonoscopy by a low-ADR endoscopist (the low-ADR group).

Baseline patient characteristics were age, sex, body mass index, past malignancy except CRC, first-degree relative with a history of CRC, smoking (Brinkman score ≥ 400), drinking (≥ 1 cup of alcohol per day), indication for colonoscopy (evaluation of symptoms, screening, or polyp surveillance), bowel preparation grade (A, B, or C), and the type of colonoscope (290 series or 260 series) . These characteristics were clinically important and reported to be associated with colon polyp detection [@JR1803-7] [@JR1803-9] [@JR1803-15] [@JR1803-18] [@JR1803-22] [@JR1803-23] [@JR1803-24] [@JR1803-25] [@JR1803-26] .

To reduce the effects of selection bias and potential confounding factors in this study, we performed rigorous adjustments for significant differences in all the baseline characteristics of patients by using propensity-score matching [@JR1803-27] [@JR1803-28] . Patients who underwent colonoscopy by high-ADR endoscopists were identified and propensity-score matched with those who underwent colonoscopy by low-ADR endoscopists. Matching was performed with a 1:1 matching protocol using nearest-neighbor matching without replacement and with a caliper width of 0.946, which was one standard deviation of logarithm odds for patients who underwent colonoscopy by low-ADR endoscopists ( [Table 1](#TB1803-1){ref-type="table"} ) [@JR1803-29] [@JR1803-30] [@JR1803-31] .

###### Baseline characteristics of patients before and after propensity-score matching.

                                                                   Before matching   After matching                                 
  ---------------------------------------------------------------- ----------------- ---------------- -------------- -------------- ------
  No. of patients                                                  418               599              334            334            
  Age [1](#FN1803-1){ref-type="table-fn"} , years                  49.9 (11.6)        53.8 (13.2)      50.2 (11.9)    50.1 (12.1)   0.91
  Sex, female                                                      213               334              171            170            0.94
  Body mass index [1](#FN1803-1){ref-type="table-fn"} , kg/m ^2^    22.1 (3.0)        22 (3.1)         22.1 (2.9)     22.0 (3.0)    0.82
  Past malignancy except CRC, %                                      7.9               7.9              7.8            6.6          0.55
  Family history of CRC, %                                          14.6              14.5             14.1           13.5          0.82
  Smoking, %                                                        11.7               9.7             10.8           10.2          0.80
  Drinking, %                                                       28.0              22.7             25.7           24.3          0.66
  Indication for colonoscopy                                                                                                        
  Evaluation of symptoms                                           109               145               85             87            
  Screening                                                        174               309              152            152            0.90
  Polyp surveillance                                               135               145               97             95            0.83
  Bowel preparation grade [2](#FN1803-2){ref-type="table-fn"}                                                                       
  A                                                                244               278              181            176            
  B                                                                146               241              125            132            0.61
  C                                                                 28                80               28             26            0.87
  Colonoscope type                                                                                                                  
  260 series                                                       110                25               26             24            
  290 series                                                       308               574              308            310            0.77

The caliper width was set to 0.946 (one standard deviation of logarithm odds for the patients who underwent colonoscopy by low-ADR endoscopists). *P* values were calculated by the Wald test using logistic regression.

ADR, adenoma detection rate; CRC, colorectal cancer.

Mean (standard deviation).

Bowel preparation: A, all colon segments empty and clean or minor amount of fluid in the gut, but easily removed by suction; B, at least one colon segment with residual amounts of brown liquid or semi-solid stool that could be easily removed or displaced; C, at least one colon segment with only partially removable stool preventing complete visualization of mucosa.

Following the propensity-score matching, we compared the polyp detection rates, numbers of polyps per procedure, and the colonoscopy procedures between the two groups. The polyp detection rates included ADRs, advanced ADRs, low-risk ADRs, high-risk ADRs, SSP detection rates, and adenoma plus SSP detection rates. The numbers of polyps included the total number of adenomas, number of adenomas by location, number of adenomas by morphology, number of adenomas by size, number of SSPs, and number of adenomas plus SSPs. The colonoscopy procedures included insertion time, withdrawal time including the time required for polypectomy, and whether PCC was performed. We assessed *P* values by using the Wald test with logistic regression.

Statistical significance was considered a two-sided *P*  \< 0.05. All statistical analyses were performed using R version 3.5.1(R Core Team 2018, R Foundation for Statistical Computing, Vienna, Austria)

Results
=======

Study population
----------------

We identified 1017 individuals who met our inclusion criteria ( [Fig. 1](#FI1803-1){ref-type="fig"} ). These patients underwent colonoscopy by 13 endoscopists. The average ADR of the endoscopists during this period was 37.0 %. We defined 11 physicians as low-ADR (26.1 %, range 18.2 %--35.1 %) endoscopists and two physicians as high-ADR (44.6 %, range 37.6 %--45.3 %) endoscopists. Of the 1017 patients, we divided 418 into low-ADR group and 599 into high-ADR group. Prior to propensity-score matching, there were differences between the two groups in the baseline patient characteristics of age, bowel preparation, and the colonoscope used ( [Table 1](#TB1803-1){ref-type="table"} ). Using propensity-score matching, 334 patients in the high-ADR group were matched with 334 patients in the low-ADR group. After matching, there was no longer any significant difference between the two groups with respect to any of the baseline characteristics.

![Flowchart of patient enrollment and propensity-score matching. ADR, adenoma detection rate.](10-1055-a-1136-9971-i1803ei1){#FI1803-1}

Outcomes for the matched patients
=================================

A comparison of outcomes between the matched patients in the low-ADR group and the high-ADR group is shown in [Table 2](#TB1803-2){ref-type="table"} . The ADR was 44.0 % and 26.9 % for the high-ADR and low-ADR endoscopists, respectively. The number of adenomas detected in the high-ADR group was higher than that in the lower-ADR group. The number of adenomas per positive procedure of the high-ADR group was higher than that of the low-ADR group. The number of adenomas identified in the proximal colon, type 0-II adenomas, and adenomas ≤ 5 mm was larger in the high-ADR group than that in the low-ADR group (all *P*  \< 0.001). The number of adenomas detected in the distal colon and rectum, type 0-I adenomas, and adenomas ≥ 6 mm was similar between both the groups. Advanced ADR was similar for both the groups; however, the high-risk ADR in the high-ADR group was higher than that in the low-ADR group ( *P*  = 0.028). The number of SSPs in the high-ADR group was larger than that in the low-ADR group ( *P*  = 0.041). Insertion time and withdrawal time in the high-ADR group were shorter than that in the low-ADR group. PCC was more frequently performed in the high-ADR group than in the low-ADR group ( *P*  \< 0.001).

###### Comparison of outcomes in patients who underwent colonoscopy by low-ADR endoscopists and patients who underwent colonoscopy by high-ADR endoscopists after propensity-score matching.

                                                                      Low-ADR group         High-ADR group        *P* value
  ------------------------------------------------------------------- --------------------- --------------------- -----------
  Adenoma detection rate (95 % CI)                                    26.9 % (22.2--31.7)   44.0 % (38.7--49.3)   \< 0.001
  No. of adenomas [1](#FN1803-3){ref-type="table-fn"}                 0.374 (0.719)         0.751 (1.069)         \< 0.001
  No. of adenomas [2](#FN1803-4){ref-type="table-fn"}                 1.389 (0.714)         1.707 (1.069)         0.0080
  No. of adenomas by location [1](#FN1803-3){ref-type="table-fn"}                                                 
  Proximal colon                                                      0.180 (0.456)         0.533 (0.902)         \< 0.001
  Cecum                                                               0.033 (0.179)         0.078 (0.290)         0.016
  Ascending colon                                                     0.087 (0.303)         0.204 (0.537)         \< 0.001
  Transverse colon                                                    0.060 (0.250)         0.251 (0.567)         \< 0.001
  Distal colon                                                        0.156 (0.424)         0.192 (0.501)         0.32
  Descending colon                                                    0.045 (0.221)         0.030 (0.171)         0.33
  Sigmoid colon                                                       0.111 (0.333)         0.162 (0.456)         0.10
  Rectum                                                              0.039 (0.194)         0.027 (0.162)         0.39
  Rs                                                                  0.027 (0.162)         0.012 (0.109)         0.16
  Ra                                                                  0.006 (0.077)         0.003 (0.055)         0.56
  Rb                                                                  0.006 (0.077)         0.012 (0.109)         0.41
  No. of adenomas by morphology [1](#FN1803-3){ref-type="table-fn"}                                               
  Type 0-I                                                            0.087 (0.322)         0.081 (0.314)         0.81
  0-Ip                                                                0.006 (0.077)         0.003 (0.055)         0.56
  0-Is                                                                0.081 (0.314)         0.078 (0.310)         0.90
  Type 0-II                                                           0.287 (0.611)         0.671 (0.998)         \< 0.001
  0-IIa                                                               0.287 (0.611)         0.659 (0.988)         \< 0.001
  0-IIc                                                               0.000 (0.000)         0.012 (0.109)         0.045
  No. of adenomas by size [1](#FN1803-3){ref-type="table-fn"}                                                     
   ≤ 5 mm                                                             0.293 (0.598)         0.683 (1.011)         \< 0.001
  1--3 mm                                                             0.222 (0.513)         0.512 (0.823)         \< 0.001
  4--5 mm                                                             0.072 (0.281)         0.171 (0.436)         \< 0.001
  6--9 mm                                                             0.060 (0.250)         0.057 (0.245)         0.88
   ≥ 10 mm                                                            0.021 (0.143)         0.012 (0.109)         0.36
  Advanced adenoma detection rate                                     2.10 %                1.20 %                0.37
  Low-risk adenoma detection rate                                     23.7 %                36.8 %                \< 0.001
  High-risk adenoma detection rate                                    3.29 %                7.19 %                0.028
  SSP detection rate                                                  7.49 %                10.5 %                0.18
  No. of SSPs [1](#FN1803-3){ref-type="table-fn"}                     0.081 (0.284)         0.141 (0.453)         0.041
  Adenoma + SSP detection rate                                        32.6 %                49.4 %                \< 0.001
  No. of adenomas + SSPs [1](#FN1803-3){ref-type="table-fn"}          0.455 (0.761)         0.892 (1.178)         \< 0.001
  Procedure                                                                                                       
  Insertion time [3](#FN1803-5){ref-type="table-fn"} , minutes        5.683 (2.873)         4.117 (2.030)         \< 0.001
  Withdrawal time [3](#FN1803-5){ref-type="table-fn"} , minutes       14.243 (5.407)        12.964 (2.850)        \< 0.001
  Pancolonic chromoendoscopy                                          88.6 %                98.2 %                \< 0.001

*P* values were calculated by the Wald test using logistic regression.

ADR, adenoma detection rate; CI, confidence interval; SSP, sessile serrated polyp.

Mean per procedure (standard deviation).

Mean per positive procedure (standard deviation).

Mean (standard deviation).

Discussion
==========

ADR is associated with the incidence and mortality of CRC, and an improvement in the ADR also reduces the incidence of CRC and its mortality [@JR1803-3] [@JR1803-4] [@JR1803-5] [@JR1803-6] . In the present study, low-ADR endoscopists missed more proximal, nonprotruding, and/or diminutive adenomas. Some studies showed that patients who developed interval CRC are more likely to have proximal cancer than those with distal cancer [@JR1803-32] [@JR1803-33] . There are some possible reasons for the distribution of interval CRC. One hypothesis is that some physicians may more often miss adenomas in the proximal colon than in the distal colon [@JR1803-34] . Lieberman *et al.* [@JR1803-13] described that failure to fully examine the proximal colon, quality of bowel preparation, variable equipment of colonoscopy, and the endoscopist's skill could lead to overlooking of the adenomas. Another possible reason is the biological differences between neoplastic lesions in the proximal and the distal colon, such as the sessile serrated lesions [@JR1803-35] . Interval cancers are more likely located in the proximal colon, have microsatellite instability, and have CpG island methylator phenotype. The mismatch repair defects correlated to microsatellite instability may induce a rapid accumulation of mutations and accelerated cancer development [@JR1803-36] [@JR1803-37] . Rondagh *et al.* [@JR1803-38] have reported that proximal adenomas with high-grade dysplasia/early CRC were more likely to be diminutive or nonpolypoid than the distal ones. Low-ADR endoscopists should be aware of the features of these missed adenomas and improve their ADRs.

Expert detectors more frequently diagnosed not only adenomas but also high-risk adenomas than the low-ADR endoscopists did. Guidelines for colonoscopy surveillance after screening and polypectomy issued by the United States Multi-Society Task Force on CRC recommend that patients without an adenoma undergo surveillance at 10 years, those with low-risk adenomas undergo surveillance at 5 to 10 years, and those with high-risk adenomas undergo surveillance at 3 years [@JR1803-13] . If a patient undergoes colonoscopy by a low-ADR endoscopist, not only do adenomas with the potential for cancerization remain, but the surveillance interval also becomes longer, which increases the patient's chances of developing CRC. It might be better to adjust the surveillance colonoscopy interval taking into account the individual ADR of the baseline endoscopist.

In this study, advanced ADR was similar for both the groups. Greenspan *et al.* [@JR1803-39] reported that advanced ADR was variable among colonoscopists with acceptable ADRs and that colonoscopists' advanced ADRs were independent of their nonadvanced ADRs. Their results support our findings. Lee *et al.* [@JR1803-40] described that measuring total adenoma detection (mean number of adenomas per procedure and mean number of adenomas per positive procedure) as adjuncts to ADR may further enhance quality assurance. Our study revealed that the mean number of adenomas per positive procedure of the high-ADR group was significantly higher than that of the low-ADR group, and withdrawal time in the high-ADR group was shorter than that in the low-ADR group. The high-ADR endoscopists in this study efficiently detected and removed adenomas.

High-ADR endoscopists more frequently conducted PCC than the low-ADR endoscopists did. We have previously reported that PCC using the new-generation endoscopy system could detect proximal colon adenomas in addition to white-light observation and NBI observation [@JR1803-24] . Low-ADR endoscopists should consider applying PCC as one of the methods to raise their ADRs.

There are some possible limitations of our study. This study was a retrospective propensity-score matching comparison. Propensity-score matching might have resulted in some biases. The present study was conducted in a single center. The calculated number of colonoscopies per one endoscopist is small. This appears slightly suboptimal for the formal calculations of ADR and other parameters. ADR now is mainly referred for colonoscopies performed for CRC screening; however, our examination involved indication for symptom evaluation and for polyp surveillance. Patients with residual polyps that could not be removed in our clinic were excluded from the analysis. Withdrawal time included time taken for maneuvers such as polypectomy that were performed during the withdrawal phase. It was difficult to subtract polyp removal time from withdrawal time due to the retrospective study design. Interobserver variability in polyp size could have resulted in some bias. We defined an endoscopist with an ADR lower than the average ADR in this study as a low-ADR endoscopist. Consequently, the mean ADR of low-ADR endoscopists was 26.1 % which was more than 25 % of the recommendation for benchmark ADR [@JR1803-41] . In the future, investigation based on the benchmark ADR is desirable. The bowel preparation scale of this study was not a gold standard. We should have used Boston Bowel Preparation Scale or Aronchick Scale, which are international standards [@JR1803-42] . Studies should be planned to address these aspects and corroborate our findings.

Conclusion
----------

In conclusion, expert detectors often found proximal, nonprotruding, and diminutive colorectal polyps and demonstrated an increased high-risk ADR.
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